Company Filing History:
Years Active: 2002-2021
Title: Jan K Kitajewski: Innovator in Medical Research
Introduction
Jan K Kitajewski is a prominent inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 10 patents to his name, Kitajewski's work has the potential to impact the lives of many patients.
Latest Patents
Among his latest patents, Kitajewski has developed methods for treating inflammatory diseases of the digestive system using trefoil family factor proteins. This invention provides methods for administering a trefoil family molecule to treat digestive system cancers and promote cell proliferation. Additionally, he has created human Notch1 based fusion proteins that serve as decoy inhibitors of jagged-notch signaling and DLL-notch signaling. This invention includes a composition that can be used to treat age-related macular degeneration (AMD), diabetic retinopathy, or cancer by administering the fusion proteins in an effective amount.
Career Highlights
Kitajewski is affiliated with Columbia University, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to developing novel therapeutic strategies that address critical health challenges.
Collaborations
Throughout his career, Kitajewski has collaborated with notable colleagues, including Carrie Shawber and Yasuhiro Funahashi. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Jan K Kitajewski's contributions to medical research exemplify the spirit of innovation and dedication to improving patient outcomes. His patents reflect a deep understanding of complex biological processes and a commitment to translating research into practical applications.